Participation in cysteinyl leukotrienes and thromboxaneA2 in nasal congestion model in Brown Norway rats

International Immunopharmacology

Volumn 7, Issue 11, 2007, Pages 1483-1487

  Kishi, Yuko ^a   Nakano, Yoshiyuki ^a   Jiang, Shuishi ^a   Yatsuzuka, Rie ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cysteinyl leukotrienes; Nasal congestion; Penh; ThromboxaneA2

Indexed keywords

PEPTIDOLEUKOTRIENE; PRANLUKAST; RAMATROBAN; SERATRODAST; THROMBOXANE A2; TOLUENE DIISOCYANATE; ZAFIRLUKAST;

ANIMAL EXPERIMENT; ARTICLE; BROWN NORWAY RAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; MALE; NEWBORN; NONHUMAN; NOSE CONGESTION; PRIORITY JOURNAL; RAT; SNEEZING;

ANIMALS; BENZOQUINONES; CARBAZOLES; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPTANOIC ACIDS; LEUKOTRIENES; MALE; MEMBRANE PROTEINS; RATS; RATS, INBRED BN; RECEPTORS, LEUKOTRIENE; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RHINITIS; SNEEZING; SULFONAMIDES; THROMBOXANE A2; TOSYL COMPOUNDS;

EID: 34548126486     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.05.020     Document Type: Article

References (28)

1. Skoner D.P. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 108 1 Suppl (2001) S2-S8
2. Howarth P.H., Salagean M., and Dokic D. Allergic rhinitis: not purely a histamine-related disease. Allergy 55 Suppl 64 (2000) 7-16
3. White M.V., and Kaliner M.A. Mediators of allergic rhinitis. J Allergy Clin Immunol 90 4 Pt 2 (1992) 699-704
4. Naclerio R.M., Meier H.L., Kagey-sobotka A., Adkinson Jr. N.F., Meyers D.A., Norman P.S., et al. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 128 4 (1983) 597-602
5. Bachert C. Histamine - a major role in allergy?. Clin Exp Allergy Suppl. 6 (1998) 15-19
6. White M.V. The role of histamine in allergic diseases. J Allergy Clin Immunol 86 4 Pt 2 (1990) 599-605
7. Krause H.F. Therapeutic advances in the management of allergic rhinitis and urticaria. Otolaryngol Head Neck Surg 111 3 Pt 2 (1994) 364-372
8. Du Buske L.M. Clinical comparison of histamine H1-receptor antagonist drugs. J Allergy Clin Immunol 98 6 Pt 3 (1996) S307-S318
9. Meltzer E.O., Malmstrom K., Lu S., Prenner B.M., Wei L.X., Weinstein, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 105 5 (2000) 917-922
10. Fujita M., Yonetomi Y., Shimouchi K., Takeda H., Aze Y., Kawabata K., et al. Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs. Eur J Pharmacol 369 3 (1999) 349-356
11. Fox C.C., Kagey-Sobotka A., Schleimer R.P., Peters S.P., MacGlashan Jr. D.W., and Lichtenstein L.M. Mediator release from human basophils and mast cells from lung and intestinal mucosa. Int Arch Allergy Appl Immunol 77 1-2 (1985) 130-136
12. 2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Inflamm Res 50 9 (2001) 466-473
13. 2 to induce allergic late phase nasal blockage in guinea pigs. Prostaglandins Other Lipid Mediat 74 1-4 (2004) 125-137
14. 1-antagonists. Int Immunopharmacol 6 5 (2006) 759-763
15. Storms W.W. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 104 5 Suppl (2004) S146-S153
16. Haberal I., and Corey J.P. The role of leukotrienes in nasal allergy. Otolaryngol Head Neck Surg 129 3 (2003) 274-279
17. Yasui K., Asamura F., and Arimura A. Inhibitory effect of a TP-receptor antagonist, S-1452, on antigen-induced nasal plasma exudation in guinea pig model for allergic rhinitis. Pharmacology 63 (2001) 65-70
18. Gelfand E.W. Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 114 5 Suppl (2004) S135-S138
19. Bisgaard H., Olsson P., and Bende M. Leukotriene D4 increases nasal blood flow in humans. Prostaglandins 27 4 (1984) 599-604
20. Mizutani N., Nabe T., Imai A., Sakurai H., Takenabe H., and Kohno S. Markedly increased nasal blockage by intranasal leukotriene D4 in an experimental allergic rhinitis model: contribution of dilated mucosal blood vessels. Jpn J Pharmacol 86 (2001) 170-182
21. 2 and histamine in experimental allergic rhinitis of guinea pigs. J Pharmacol Exp Ther 280 3 (1997) 1471-1479
22. 2 in antigen-induced nasal blockage in guinea pigs. Int Arch Allergy Immunol 112 4 (1997) 400-405
23. Taylor-Clark T., and Foreman J. Histamine-mediated mechanisms in the human nasal airway. Curr Opin Pharmacol 5 3 (2005) 214-220
24. 1 receptors. Eur J Pharmacol 449 3 (2002) 287-291
25. 2 receptor antagonist (Bay u 3405) on nasal symptoms after antigen challenge in sensitized guinea pigs. Int Arch Allergy Immunol 109 2 (1996) 161-166
26. 2 by human helper T cell subsets. J Immunol 164 5 (2000) 2277-2280
27. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193 2 (2001) 255-261
28. Nagata K., Hirai H., Tanaka K., Aso T., Suganuma K., Nakamura M., et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 459 2 (1999) 195-199